DCF — SO TENN REG MED CTR OF PULASKI
Enterprise Value: $21.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$21.5M
Enterprise Value
$5.2M
PV of Cash Flows
$16.3M
PV of Terminal Value
$26.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $45.9M | $3.2M | 7.0% | $0.8M | $0.7M |
| Year 2 | $47.3M | $3.8M | 8.0% | $1.1M | $0.9M |
| Year 3 | $48.7M | $4.4M | 9.0% | $1.5M | $1.2M |
| Year 4 | $50.1M | $4.8M | 10.0% | $1.8M | $1.2M |
| Year 5 | $51.6M | $5.0M | 10.0% | $1.9M | $1.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $21.5M. Terminal value accounts for 76% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$44.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.0651890917864587
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5